Sigyn Therapeutics, Inc.
SIGY· OTC
SIGYSigyn Therapeutics, Inc.
Filed May 9, 2016 · 10-Q · 39 days after period end · 0001615774-16-005280
| Metric | Q1 2016 | Q1 2015 |
|---|---|---|
| Revenue | — | $10.77K |
| Net Income | -$851.24K | -$151.80K |
| EPS Diluted | -$0.02 | -$0.01 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Sigyn Therapeutics, Inc. · CIK 1642159 · Engraved from SEC EDGAR
ended Mar 31, 2016 · filed May 9, 2016 · 39 d after period end
